Drug Type Synthetic peptide |
Synonyms- |
Target |
Action modulators |
Mechanism RXFP4 modulators(relaxin family peptide/INSL5 receptor 4 modulators) |
Therapeutic Areas |
Active Indication |
Inactive Indication- |
Originator Organization |
Active Organization |
Inactive Organization- |
License Organization- |
Drug Highest PhasePreclinical |
First Approval Date- |
Regulation- |
| Indication | Highest Phase | Country/Location | Organization | Date |
|---|---|---|---|---|
| Constipation | Preclinical | Australia | 21 Nov 2024 |






